Borrower record · Q2 2026
Coherus Biosciences
As filed by 3 BDCs · period end 30 June 2026Filers label it: Healthcare & Pharmaceuticals (3)1 name variant under review
Three lenders report $21.5m of Coherus Biosciences at Q2 2026, marked at 104.5 cents. First-Lien Senior Secured on all three positions whose seniority a filer disclosed.
- Filed fair value
- $21.5m
- 6 funded positions
- Reporting lenders
- 3
- across 6 filed positions
- Aggregate mark
- 104.5c
- cost filed on all 6 positions
- Median spread
- 800bp
- over SOFR, 3 tranches
- Maturities to
- 2029
- one date, 1 May 2029
- Periods on record
- 5
- Q2 2025 → Q2 2026
How this total is counted
- Every figure above is the sum of 6 funded positions filed by 3 BDCs, each one cited below.
- Counted from the Q2 2026 filings imported for this build, the latest of them filed 20 August 2026. A schedule filed after that date is not in these figures and will appear when the property is rebuilt.
- 1 filed name variant is under review against this borrower. Until it is resolved, anything filed under that name is counted nowhere on this page.
Pricing as filed
3 floating tranches · SOFR800bp on all 3 floating tranches — every filer reports the same spread.
Capital structure
First-Lien Senior Secured, on all 3 positions whose seniority a filer disclosed.
3 of 6 funded positions carry no filed seniority. Whether to classify is the filer's choice, so the unclassified value is not split here.
Rate structure
Floating, on all 3 positions whose interest type a filer disclosed.
3 of 6 funded positions carry no filed interest type.
Maturity profile
3 of 6 funded positions dated2.8 years to maturity, weighted by fair value across the 3 dated positions.
Filed over time
5 periods · aggregate onlyFiled fair value
Aggregate marknot to zero
Q2 2025, Q3 2025, Q4 2025, Q1 2026, Q2 2026 — every filer reporting the borrower at each period, aggregated. No lender is separated out at any period.
Credit flags
No lender reports this borrower on non-accrual, and no filed tranche pays in kind.
Not in the filings
- No sector. 3 filers file the same industry string, shown above as filed, but it has not cleared the corroboration test.
- No filed seniority on 3 of 6 funded positions.
- No maturity on 3 of 6 funded positions. Undated is left undated, not assumed.
- No mark dispersion. Fewer than four filers disclosed a cost, so the distance between the highest and lowest mark would place each of them.
Sign up for free
Who holds it, and where they mark it.
3 lenders hold the same credit and mark it differently. Behind the gate, one row each — for this borrower and for every other one on this site, free and with no limit on how many you read.
- The spread between the highest and lowest lender mark
- Quarter-on-quarter movement across 5 periods
- Peer comparison against borrowers with the same lenders
- The 10-Q or 10-K behind every row, by accession number
Every filing behind this page
3 filers · Q2 2026| Filer | CIK | Form | Period | Filed | Accession |
|---|---|---|---|---|---|
| Barings BDC, Inc. (BBDC) | 0001379785 | 10-Q | 2026-06-30 | 2026-08-05 | 0001379785-26-000030 |
| Barings Capital Investment Corp | 0001811972 | 10-Q | 2026-06-30 | 2026-08-05 | 0001811972-26-000018 |
| Barings Private Credit Corp | 0001859919 | 10-Q | 2026-06-30 | 2026-08-05 | 0001859919-26-000068 |
Related borrowers
Same lenders